Jing Zhang

Dr. Jing Zhang

Tianjin Medical University
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Aging Cell
Verified
Journal Article
Open access
JZJing Zhang
Jing Zhang
HYHaoyue Yu
Haoyue Yu
MMMao-Qiang Man
Mao-Qiang Man
LHLizhi Hu
Lizhi Hu
Skin aging is characterized by changes in its structural, cellular, and molecular components in both the epidermis and dermis. Dermal aging is distinguished by reduced dermal thickness, increased wrinkles, and a sagging appearance. Due to intrinsic or extrinsic factors, accumulation of excessive reactive oxygen species (ROS) triggers a series of aging events, including imbalanced extracellular matrix (ECM) homeostasis, accumulation of senescent fibroblasts, loss of cell identity, and chronic inflammation mediated by senescence‐associated secretory phenotype (SASP). These events are regulated by signaling pathways, such as nuclear factor erythroid 2‐related factor 2 (Nrf2), mechanistic target of rapamycin (mTOR), transforming growth factor beta (TGF‐β), and insulin‐like growth factor 1 (IGF‐1). Senescent fibroblasts can induce and accelerate age‐related dysfunction of other skin cells and may even cause systemic inflammation. In this review, we summarize the role of dermal fibroblasts in cutaneous aging and inflammation. Moreover, the underlying mechanisms by which dermal fibroblasts influence cutaneous aging and inflammation are also discussed.

1 June 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LHLizhi Hu
Lizhi Hu
TMTheodora M. Mauro
Theodora M. Mauro
EDErle Dang
Erle Dang
GMGeorge Man
George Man
JZJing Zhang
Jing Zhang
MMMao-Qiang Man
Mao-Qiang Man

1 November 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YOYuko Oda
Yuko Oda
LHLizhi Hu
Lizhi Hu
TNThai Nguyen
Thai Nguyen
CFChak Fong
Chak Fong
JZJing Zhang
Jing Zhang
DBDaniel Bikle
Daniel Bikle

5 February 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YLYingxi Li
Yingxi Li
JWJiangmei Wu
Jiangmei Wu
YTYao Tian
Yao Tian
QZQianyu Zhu
Qianyu Zhu
YGYicheng Ge
Yicheng Ge
LHLizhi Hu
Lizhi Hu

15 April 2016 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
HZHuiling Zhu
Huiling Zhu
YLYulan Liu
Yulan Liu
SCShaokui Chen
Shaokui Chen
XWXiuying Wang
Xiuying Wang
DPDingan Pi
Dingan Pi
PKPing Kang
Ping Kang
Stress induces injury in intestinal barrier function in piglets. Long-chainn-3 PUFA have been shown to exhibit potential immunomodulatory and barrier protective effects in animal models and clinical trials. In addition, corticotropin-releasing hormone (CRH)/CRH receptor (CRHR) signalling pathways play an important role in stress-induced alterations of intestinal barrier function. We hypothesised that fish oil could affect intestinal barrier function and CRH/CRHR signalling pathways. In total, thirty-two weaned pigs were allocated to one of four treatments. The experiment consisted of a 2×2 factorial design, and the main factors included immunological challenge (saline or lipopolysaccharide (LPS)) and diet (5 % maize oil or 5 % fish oil). On d 19 of the trial, piglets were treated with saline or LPS. At 4 h after injection, all pigs were killed, and the mesenteric lymph nodes (MLN), liver, spleen and intestinal samples were collected. Fish oil decreased bacterial translocation incidence and the number of translocated micro-organisms in the MLN. Fish oil increased intestinal claudin-1 protein relative concentration and villus height, as well as improved the intestinal morphology. In addition, fish oil supplementation increased intestinal intraepithelial lymphocyte number and prevented elevations in intestinal mast cell and neutrophil numbers induced by LPS challenge. Moreover, fish oil tended to decrease the mRNA expression of intestinalCRHR1,CRHand glucocorticoid receptors. These results suggest that fish oil supplementation improves intestinal barrier function and inhibits CRH/CRHR1 signalling pathway and mast cell tissue density.

1 November 2013 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
ZZZhen Zhang
Zhen Zhang
WLWeiran Liu
Weiran Liu
LZLei Zhang
Lei Zhang
SWStephanie Woo
Stephanie Woo
ATAnliu Tang
Anliu Tang
KZKai Zhang
Kai Zhang
Background: This study aims to analyze the current status of postoperative pain management in the People's Republic of China's provincial-level hospitals, and the existing knowledge and opinions held by patients regarding these methods. Methods: The 128 participants in this study were urology and hepatobiliary patients from three provincial-level hospitals in Hunan. The questionnaire assessing postoperative pain was designed using the typical pain assessment scales and pain management guidelines as references. Results: 82.8% of study participants claimed that their postoperative pain was relieved within 3 days of their operations. However, while 91.4% of surveyed patients experienced moderate to severe pain, 51.6% received no treatment for their postoperative pain, and 14.9% complained that medical personnel failed to manage their pain. 20.2% were unsatisfied with their pain management, indicating that treatment did not meet their expectations. Furthermore, participants demonstrated a great misunderstanding of pain and analgesics, as 72.6% of patients were unfamiliar with morphine, 51.6% of patients believed only certain types of pain required management, and 18.5% refused to use morphine. Conclusion: In most Chinese provincial-level hospitals, current postoperative pain management methods are able to alleviate the pain experienced by the majority of patients, though pain assessment and therapy procedures are still not standardized. Furthermore, most patients lack a proper understanding of postoperative pain and analgesics. Therefore, pain management education for doctors and patients and their relatives should be implemented in order to improve the quality of postoperative pain management.